Previous Article | Next Article 
Applied and Environmental Microbiology, April 2000, p. 1416-1422, Vol. 66, No. 4
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Isolation of Bacteriophages Specific to a Fish
Pathogen, Pseudomonas plecoglossicida, as a Candidate
for Disease Control
Se Chang
Park,1
Ichiro
Shimamura,2
Minoru
Fukunaga,2
Koh-Ichiro
Mori,3 and
Toshihiro
Nakai1,*
Fish Pathology Laboratory, Faculty of Applied
Biological Science, Hiroshima University, Higashi-hiroshima,
Hiroshima,1 Tokushima Prefectural
Fisheries Experimental Station, Hiwasa,
Tokushima,2 and Kamiura Station,
Japan Sea-Farming Association, Kamiura, Oita,3
Japan
Received 25 October 1999/Accepted 6 January 2000
 |
ABSTRACT |
Two types of bacteriophage specific to Pseudomonas
plecoglossicida, the causative agent of bacterial hemorrhagic
ascites disease in cultured ayu fish (Plecoglossus
altivelis), were isolated from diseased ayu and the
rearing pond water. One type of phage, which formed small plaques,
was tentatively classified as a member of the family
Myoviridae, and the other type, which formed large plaques,
was classified as a member of the family Podoviridae. All
27 strains of P. plecoglossicida examined, which were
isolated from diseased ayu from geographically different areas in 1991 to 1999, exhibited quite similar sensitivities to either type of phage.
One strain of P. plecoglossicida was highly virulent for
ayu, and the 50% lethal dose (LD50) when
intramuscular injection was used was 101.2 CFU
fish
1; in contrast, phage-resistant variants of this
organism were less virulent (LD50, >104 CFU
fish
1). Oral administration of phage-impregnated feed to
ayu resulted in protection against experimental infection with P. plecoglossicida. After oral administration of P. plecoglossicida cells of this bacterium were always detected
in the kidneys of control fish that did not receive the phage
treatment, while the cells quickly disappeared from the phage-treated
fish. Bacterial growth in freshwater was lower in the presence of
phage, and the number of phage PFU increased rapidly. These results
suggest that it may be possible to use phage to control the disease
caused by P. plecoglossicida.
 |
INTRODUCTION |
Ayu, Plecoglossus
altivelis, is the most popular freshwater fish for culture and
sport fishing in Japan. For a long time vibriosis caused by
Vibrio anguillarum was the most serious disease in cultured populations of ayu, but this disease was replaced by coldwater disease
caused by Flavobacterium psychrophilum (4) in the
late 1980s (5, 32). F. psychrophilum has been
recognized as an important pathogen of salmonid fish worldwide for a
long time (21). More recently, however, a new bacterial
disease with a high level of mortality has prevailed among cultured
ayu, and this disease causes serious damage to the ayu culture industry in Japan. The bacterium that causes this disease is similar to Pseudomonas putida, but some of its biochemical
characteristics differ from characteristics of typical strains of
P. putida (14, 31); a new species name,
Pseudomonas plecoglossicida, has been proposed for this
bacterium (15). The disease caused by P. plecoglossicida often occurs a short time after naturally or
artificially produced fish are introduced into culture ponds, and it
also occurs at any developmental stage during culture, particularly
after chemotherapy for F. psychrophilum infection. At
present, there are no licensed chemotheraputic compounds that are
effective against the new disease and no procedures which can be used
to control the disease other than reducing predisposing factors, such
as overcrowding and overfeeding.
Theoretically, bacteriophages can be used to treat infectious disease,
but little attention has been paid to phage therapy and prophylaxis
after the early uncontrolled studies (3, 19). However, in
the 1980s interesting studies on phage therapy were carried out by
Smith and his colleagues, who used Escherichia coli
infection models with mice and farm animals, and the results indicated
that phage could be used for both treatment and prophylaxis (23-26). In addition, a series of successful phage
therapies for human bacterial infections was described by Slopek et al.
(22), although the clinical studies performed with humans
did not provide scientifically important information. After this, many
controlled experiments indicated that it may be possible to use phage
therapy in animal models (2, 10, 27, 28). On the other hand, phages of some fish-pathogenic bacteria have been described (9, 18, 20, 30, 33), but there have been few attempts to use phage to
control bacterial infections in fish. Our recent investigations of
phage specific to Lactococcus garvieae (formerly
Enterococcus seriolicida), a pathogen of yellowtail
(Seriola quinqueradiata) and other marine fishes (7,
8), suggest that phage could be useful for controlling bacterial
infections of fish (13, 16, 17).
In the present study, we isolated P. plecoglossicida-specific phages from diseased ayu and culture pond
water, characterized these phages, and examined the effects of isolated
phages on experimental infections with P. plecoglossicida.
Below we discuss the potential for phage control of the disease caused
by P. plecoglossicida.
 |
MATERIALS AND METHODS |
Bacteria and media.
Twenty-three bacterial strains which
were isolated from diseased ayu obtained in seven prefectures in Japan
from 1991 to 1999 were used in this study (Table
1). These strains were gram-negative, aerobic, motile or nonmotile rods and were identified as P. plecoglossicida based on other phenotypic characteristics of this
species (15). The motility of the bacteria was examined
directly (wet mount method) by using a microscope. Two motile strains
(strains FPC941 [= ATCC 700384] and FPC951 [= ATCC
700383T]) and two nonmotile strains (strains PH-9501 and
AK-9510) described previously (14, 15, 31) were used as
reference strains. All 27 strains exhibited positive reactions in the
slide agglutination test with an rabbit antiserum raised against
P. plecoglossicida FPC951. Laboratory stock strains of other
fish-pathogenic bacteria (Table 1) were used to determine the host
specificity of phages that were isolated. Trypto-soy broth (TSB)
(Nissui) and Trypto-soy agar (TSA) (Nissui) were used for bacterial
culture and for a phage PFU assay.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
P. plecoglossicida strains and other bacterial
strains used in this study and their motility and sensitivity to two
phage isolates
|
|
Isolation of phage and PFU assay.
Phage were isolated from
diseased ayu and culture pond water obtained at three fish farms in
Tokushima Prefecture in September 1998 by using an enrichment method
(29). Pooled kidney samples from six diseased fish were
homogenized with sterile saline and centrifuged at 3,000 × g for 10 min, and 1 ml of the supernatant was inoculated into 100 ml of TSB which had been supplemented with a mixture of seven strains
of P. plecoglossicida as indicator organisms (Table 1). For
water samples, 100 ml of pond water was filtered through a
0.45-µm-pore-size membrane filter and mixed with 100 ml of
double-strength TSB containing the indicator organisms. After 48 h
of growth at 25°C with gentle agitation, the culture was centrifuged
and filtered, and the supernatant was subjected to the following PFU
assay performed by using a double-agar-layer method (18).
The numbers of PFU was determined after 24 h of incubation at
25°C, and the efficiency of plating (EOP) was calculated. Strain
PTH-9802 was used as an indicator strain for preparation of phage stock
suspensions, which were stored at 5°C.
Electron microscopy of phage and bacteria.
A phage
suspension (109 PFU ml
1) was centrifuged with
a 20 and 60% discontinuous sucrose gradient at
100,000 × g for 90 min at 4°C. After dialysis
against 50 mM Tris-HCl buffer (pH 7.2) containing 0.2 M NaCl overnight,
phage samples were negatively stained with 4% uranyl acetate and
examined with a Hitachi model H7500 electron microscope at 80 kV.
For microscopy of bacterial flagella, four strains of P. plecoglossicida that had been grown on TSA overnight were
negatively stained.
Analysis of phage nucleic acids.
Nucleic acids of phages
were extracted with phenol saturated with TE buffer (10 mM Tris-HCl
[pH 8.0], 1 mM EDTA), and this was followed by extraction with a
mixture of choloroform and isoamyl alcohol (24:1). The purified
nucleic acids were tested for sensitivity to RNase and restriction
enzyme EcoRI. The results were determined by 1% agarose
gel electrophoresis.
Preparation of phage-resistant variants of P. plecoglossicida.
A culture of P. plecoglossicida
PTH-9802 was treated with an undiluted suspension (109
PFU ml
1) of phages PPpW-3 and PPpW-4. Colonies that
appeared on the plate after 2 days of incubation at 25°C were
purified on TSA, and selection for phage-resistant variants was
repeated. Finally, cultures that produced no PFU with 109
PFU of one phage or both phages ml
1 were used as
phage-resistant variants.
Pathogenicity test performed with P. plecoglossicida.
Phage-sensitive and phage-resistant
cells of P. plecoglossicida PTH-9802 variants were used to
study pathogenicity for ayu with an average weight of 10 g. Groups
of 10 fish were injected intramuscularly with bacteria at doses of
100 to 104 CFU per fish and then kept in
40-liter plastic tanks with flowthrough water at 20 ± 1°C.
Mortalities were recorded daily for 2 weeks, and the kidneys of dead
fish were subjected to a bacterial isolation study to confirm that
death was due to P. plecoglossicida infection; anti-FPC951 serum was used in this study.
Coculture of P. plecoglossicida and phage in water.
P. plecoglossicida PTH-9802 and phage PPpW-3 or PPpW-4 were
inoculated into filter-sterilized (pore size, 0.45 µm) rearing pond
water at doses of 102 CFU ml
1 and
103 PFU ml
1, respectively, and then the
preparations were incubated with gentle agitation at 25°C.
Preparations inoculated with either bacteria or phage were used as
controls. The numbers of bacteria and phage in water were determined 1 to 72 h after inoculation.
Phage treatment of infected fish and kinetics of inoculated
organisms.
In the first experiment, four groups of 20 ayu weighing
10 g (average weight) were fed commercial dry pellets that had
been impregnated with a live culture of P. plecoglossicida
PTH-9802 at a feeding rate of 1.5% based on body weight. After 15 min
of feeding, two of the groups were immediately fed pellets that had been impregnated with a phage suspension containing PPpW-3 and PPpW-4.
The concentrations of bacteria and phage were 107 CFU
g
1 of pellets and 107 PFU g
1 of
pellets, respectively. The other two groups received feed without phage
and served as controls. In the second experiment, four groups of 50 or
40 ayu weighing 2.4 g (average weight) were similarly fed
bacterium-impregnated pellets (107 CFU g
1),
and then two of the groups were fed phage-impregnated pellets (107 PFU g
1) 1 or 24 h after they were
fed the bacterium-impregnated pellets. The mortalities of the fish were
recorded daily for 2 weeks, and the kidneys of dead fish or survivors
at the end of the experiment (only in the first experiment) were
subjected to a bacterial isolation study as described above. The water
temperature of the fish tanks was 20 ± 1°C throughout the experiments.
Three groups of 30 ayu (average weight, 2.4 g) were used to study
the kinetics of orally administered
P. plecoglossicida and
phage in fish. The fish were fed bacterium-impregnated pellets,
phage-impregnated pellets, or bacterium-impregnated pellets followed
by
phage-impregnated pellets as described above. Groups of three
fish were
sacrificed in order to detect the inoculated phage and
bacteria in
their kidneys 3 to 168 h after inoculation (water
temperature,
22 ± 1°C). The kidneys were homogenized with 9 volumes
of
saline, centrifuged at 7,000 ×
g for 3 min to
enumerate phage
particles, and then processed for CFU and PFU
assays.
 |
RESULTS |
Isolation and characterization of phage.
Eight phage isolates
were obtained from nine samples (five pooled kidneys of diseased ayu
and four pond water samples) by the enrichment method (Table
2). Only a kidney sample from farm C was
negative for phage isolation. The phages were designated PPpA or
PPpW. Two phage isolates (PPpW-1 and PPpW-3) from pond water formed
small plaques (average diameter, 1.4 mm) after 24 h of incubation
at 25°C with every type of indicator cells; these phage isolates had
isometric heads that were 50 nm in diameter and long contractile tails
(20 by 110 nm) with spikes (Fig. 1a). Another six phage isolates, represented by PPpW-4, formed large plaques
that were 3.5 mm in diameter (average) after 24 h of incubation at
25°C; these isolates had isometric heads (diameter, 50 nm) and short
tails (25 by 18 nm) (Fig. 1b). The nucleic acids of both types of
phages were cleaved by EcoRI but not by RNase. The following
two different restriction fragment length polymorphism profiles were
produced by the phage isolates: type I (PPpW-1 and PPpW-3) and type II
(the other six isolates).

View larger version (127K):
[in this window]
[in a new window]
|
FIG. 1.
Phage plaques with P. plecoglossicida
PTH-9802 and electron micrographs of the phages. (a) PPpW-3. (b)
PPpW-4. Bars = 50 nm.
|
|
The EOPs of phages PPpW-3 and PPpW-4 with
P. plecoglossicida
PTH-9802 at different incubation temperatures are shown in Table
3. Bacteria that were not infected with
phage grew well at 10
to 30°C but not at 35°C. During a 3-day
incubation period, lytic
activity was observed at a temperature of
30°C or less for PPpW-3
and at a temperature of 25°C or less for
PPpW-4, without any significant
change in the EOP.
All 27 strains of
P. plecoglossicida examined were sensitive
to both types of phage (PPpW-3 and PPpW-4), and the EOPs at 25°C
ranged from 0.8 to 6.7; however, the other eight strains of
fish-pathogenic
bacteria tested were not susceptible to the phages
(Table
1).
Similar results were obtained with the other six phage
isolates.
When the motility of
P. plecoglossicida strains was examined
by the wet mount method, 10 of the 27 strains examined were motile
(Table
1). As determined by electron microscopy, lophotrichous
flagella
were observed in motile strain FPC941 (Fig.
2) but not
in three nonmotile strains
(PTH-9802, AK-9510, and PH-9501).
Phage-resistant bacterial variants and pathogenicity in fish.
Variants of PTH-9802 that emerged after exposure to PPpW-3 were also
resistant to PPpW-4, while variants that emerged after exposure to
PPpW-4 were sensitive to PPpW-3. Four bacterial variants, designated
R1, R2, and R3 (resistant to both phage PPpW-3 and phage PPpW-4) and R4
(resistant to only phage PPpW-4), were used in the pathogenicity test.
All of the phage-resistant variants reacted positively in slide
agglutination tests with anti-FPC951 serum. The pathogenicities
of these four variants and their parent, strain PTH-9802, for ayu
are shown in Table 4. A phage-sensitive parent PTH-9802 was highly virulent for ayu, and its 50% lethal dose
(LD50) by intramuscular injection was 101.2 CFU
fish
1. Fish died 5 to 10 days after injection and
produced bloody ascites, and the bacteria inoculated were isolated in
pure culture from kidneys of dead fish. By contrast, variants that were
resistant to PPpW-3 and/or PPpW-4 were not pathogenic for fish even at
a dose of 104 CFU fish
1.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Pathogenicities of phage-sensitive parent cells and
phage-resistant variants of P. plecoglossicida PTH-9802
for ayua
|
|
Interaction of P. plecoglossicida and phage in
water.
Bacteria inoculated into water without phage began to grow
at 6 h postinoculation (p.i.) and reached a concentration of
104 CFU ml
1 at 48 h p.i. (Fig.
3). In the presence of phage, bacterial
growth decreased until 24 or 48 h p.i., while the number of
inoculated phage temporarily decreased at 12 h p.i. and then
rapidly increased to 106 PFU ml
1 (PPpW-3) or
104 PFU ml
1 (PPpW-4) at 24 or 48 h p.i.
There were no changes in the number (PFU) of phage in the absence of
P. plecoglossicida.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Interaction of P. plecoglossicida and phage
particles in water. Phage and P. plecoglossicida PTH-9802
were coinoculated into rearing pond water and incubated at 25°C. (a)
PPpW-3. (b) PPpW-4. Symbols: , bacteria only; , bacteria
coinoculated with phage; , phage coinoculated with bacteria.
|
|
Protective effect of phage administration.
The protective
effects resulting from oral administration of phage against
experimental P. plecoglossicida infection are shown in Table
5. In the first trial, fish were orally
challenged with live P. plecoglossicida cells and received
phage-impregnated or phage-free feed. Fish in the control groups that
received feed without phage began to die 7 days after the bacterial
challenge, and the cumulative mortality in 2 weeks was 65.0% (average
for the two groups); in contrast, fish that received phage-impregnated feed died later, and the average cumulative mortality was 22.5%. The
mortality of phage-treated fish was significantly lower than the
mortality of control fish that were not treated with phage (significance level,
= 0.05 as determined by a chi-square
test). Inoculated P. plecoglossicida strains were isolated
from all of the kidneys of dead fish (n = 35)
irrespective of the phage treatment and from 3 of 14 surviving fish in
control groups but not from any of the fish that received phage and
survived (n = 31). In addition, bacteria that were
isolated from fish that had received phage and died were still
susceptible to both phages. Similar protective effects of phage
treatment, including significantly (
= 0.05) lower and delayed
mortality, were observed with fish that received phage 1 or 24 h
after bacterial challenge in the second trial, in which smaller fish
were used (Table 5).
Kinetics of P. plecoglossicida and phage inoculated
into fish.
P. plecoglossicida cells in fish that received
bacterium-impregnated feed first appeared at a concentration of
103.5 CFU g
1 in the kidney of one fish 3 h after feeding and were detected at levels of 103.9 to
106.3 CFU g
1 in all of the kidneys examined
up to 168 h later (Table 6). In fish
that received phage-impregnated feed, the inoculated phages were
detected at concentrations of 103.1 to 105.7
PFU g
1 in kidneys after 3 and 12 h but disappeared
after 24 h. On the other hand, when fish received
phage-impregnated feed after a bacterial challenge, P. plecoglossicida cells were not detected in kidneys of fish 12 h after challenge or later, and phages were detected in kidneys of some
fish 3 to 24 h after challenge.
 |
DISCUSSION |
Because of the lack of effective chemotherapy, a way to control
P. plecoglossicida infections in cultured ayu is urgently needed. Some antimicrobial agents, such as florfenicol and
sulfisozole, are used to treat coldwater disease; after such treatment,
particularly when it is coupled with overfeeding, P. plecoglossicida infection abruptly emerges and results in
high mortality levels. This is a typical example of microorganism
substitution in fish disease. Thus, it has been hypothesized that
P. plecoglossicida is an opportunistic pathogen, but our
infection experiment in which intramuscular injection was used revealed
that this bacterium is highly virulent for ayu, with an
LD50 of 101.2 CFU fish
1. This
virulence is equivalent to the reported virulence of V. anguillarum (6), which was the most
devastating pathogen of cultured ayu in the 1980s. In contrast to
V. anguillarum, which is not able to grow in medium that
does not contain sodium chloride or to survive in freshwater (1,
11), P. plecoglossicida survived and proliferated well
in freshwater in which ayu was reared (Fig. 3). This indicates that
this bacterium can be present in all ayu culture environments and that
there can be rapid horizontal transmission of the disease, although the
precise mechanisms of infection remain unknown.
Previously, we described isolation of L. garvieae-specific
phage belonging to the family Siphoviridae from fish culture
environments (seawater and sediment) by the enrichment
method (16). This method was also very useful for
isolating phage specific to P. plecoglossicida in the
present study, and two types of phages were isolated from diseased ayu
and the rearing pond water. Based on morphological and genotypic
characteristics, one type of phage, which has a long contractile tail
and forms small plaques, can be classified as a member of the family
Myoviridae, and the other type, which has a very short tail
and forms large plaques, can be classified as a member of the family
Podoviridae (12).
P. plecoglossicida strains are homogeneous with respect to
biochemical characteristics (14, 15), and our study
demonstrated that all of the bacterial isolates obtained from
geographically and chronologically different sources which we examined
were members of a single serotype and a single phage type. This makes
it possible to identify the bacterium by phage analysis. The fact that
P. plecoglossicida infection has been restricted to cultured
ayu so far may have led to the low level of diversity of the organism, although some marine fish species, such as Japanese flounder
(Paralichthys olivaceus) and red seabream (Pagrus
major), were susceptible to the bacterium in experimental
infection studies (14). However, in two previous papers
(14, 31) the authors described contrasting results for in
vitro motility of the bacterium and the presence of bloody ascites in
affected fish; both of these characteristics were positive in one study
(31), and both were negative in the other study
(14). According to our observations during disease outbreaks
in Tokushima Prefecture in 1998 and 1999, the presence of bloody
ascites was a characteristic clinical sign in diseased fish. Of the 27 isolates of P. plecoglossicida examined in the present
study, 10, including FPC941 and FPC951 (31), were motile and
17, including AK-9510 and PH-9501 (14), were not motile. The
relationship between the motility of the bacterium and different clinical conditions (bloody ascites) in affected fish remains unclear.
As pointed out previously (3, 23), it is thought that the
reasons why phages are of little value in controlling bacterial infections in humans and animals include the apparent low activity of
phages in vivo, the very narrow host specificities of phages, and the
rapid emergence of phage-resistant bacterial variants during treatment.
These hypotheses concerning phage therapy were reinforced after
successful chemotherapy with antibiotics began in the 1940s. However,
these characteristics may not be disadvantages for phage treatment in
some cases (3), including phage treatment of P. plecoglossicida infection of ayu. In this study, oral
administration of phage with feed clearly protected fish against
experimental infection, indicating that the level of phage activity in
vivo was high (Table 5). The kinetics of inoculated bacteria and phage resulted in in vivo survival of phage and in vivo killing of bacterial cells by phage (Table 6). Interestingly, phage that were administered orally appeared in the kidneys of fish without host bacterial cells as
a transport vehicle, although the time that the phage remained in the
organ was relatively short. Easy movement of phage from the alimentary
tract to the blood circulation system was also observed during human
phage therapy (22). These results indicate that orally
administered phage can be expected to kill bacterial cells in internal
organs, as well as bacterial cells in the intestine, which means that
phage therapy can be effective at the systemic infection stage. This
conclusion is supported by the finding that phage treatment was
effective even 24 h after bacterial challenge, when the infection
was systemic (Table 6). If a similar effect occurs in naturally
infected fish, bacterial cells that are disrupted by phage infection
may serve as a good unattenuated bacterin; that is, there could be two
effects of phage therapy, treatment and vaccination. In addition, the
incubation temperature required for lytic activity of the phage ranged
from 10 to 25 or 30°C, which covers the entire range of rearing water temperatures during ayu culture.
All phage isolates obtained in this study were P. plecoglossicida specific but not strain specific, suggesting that
a single phage strain or a few phage strains could provide effective
phage therapy. Further studies should be performed to select the most effective phage strain or effective combination of phage strains for
therapeutic applications. The fact that infection was established by
oral route also suggests that the intestine is an important portal of
entry for the pathogen, and the narrow host range of phage should be an
advantage in phage treatment because the phage do not harm the normal
intestinal microflora.
Phage-resistant variants of P. plecoglossicida, which were
induced in vitro, lacked virulence for ayu, and no phage-resistant variants were obtained from fish that died after phage treatment. In
successful phage control of E. coli infections in mice and calves, the phage-resistant organisms that emerged during phage treatment were the less virulent K
type organisms
(23, 24). Considering the general importance of the
bacterial cell surface as a virulence factor, a surface component
associated with bacterial virulence also seems to be the receptor for
phage attachment, and consequently phage-resistant variants of a
virulent organism would not be pathogenic. As stated previously
(2), adaptation of a pathogen and a phage in which the
bacterial surface virulence determinant is the attachment site for the
phage may be essential for successful phage therapy or control. If this
is true, P. plecoglossicida must have such a cell surface
component that is a virulence factor; this hypothesis is supported by
the fact that no toxins lethal to ayu were detected in P. plecoglossicida cultures (data not shown). From a different point
of view, phage should be useful for obtaining mutants that have
different surface characteristics as virulence factors for given
pathogenic bacteria.
In conclusion, our successful phage treatment of experimentally induced
P. plecoglossicida infection suggests that phage could be
used to control this disease. Moreover, the finding that phage can
inhibit bacterial growth in water (Fig. 3) suggests that the phage
could be used prophylactically to prevent horizontal transmission of
the pathogen. Experiments to determine the effectiveness of phage
against natural infections should be performed in order to develop a
phage control treatment for the disease.
 |
ACKNOWLEDGMENTS |
We thank the staffs of the Yamanashi, Wakayama, Kyoto, Shiga,
Hiroshima, and Miyazaki Prefectural Fisheries Experiment Stations and
H. Wakabayashi of The University of Tokyo for providing P. plecoglossicida strains and a rabbit antiserum used in this study.
This study was supported in part by grants from the Ministry of
Education and Tokushima Prefecture, Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Applied
Biological Science, Hiroshima University, Higashihiroshima
739-8528, Japan. Phone: 81-824-24-7947. Fax: 81-824-22-7059. E-mail: nakaitt{at}hiroshima-u.ac.jp.
 |
REFERENCES |
| 1.
|
Austin, B., and D. A. Austin.
1993.
Vibrionaceae representatives, p. 265-307.
In
Bacterial fish pathogens. Disease in farmed and wild fish, 2nd ed. Ellis Horwood Ltd., London, United Kingdom.
|
| 2.
|
Barrow, P.,
M. Lovell, and A. Berchieri, Jr.
1998.
Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves.
Clin. Diagn. Lab. Immunol.
5:294-298[Abstract/Free Full Text].
|
| 3.
|
Barrow, P. A., and J. S. Soothill.
1997.
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.
Trends Microbiol.
5:268-271[CrossRef][Medline].
|
| 4.
|
Bernardet, J.-F.,
P. Segers,
M. Vancanneyt,
F. Berthe,
K. Kersters, and P. Vandamme.
1996.
Cutting a gordian knot: emended classification and description of the genus Flavobacterium, emended description of the family Flavobacteriaceae, and proposal of Flavobacterium hydatis nom. nov. (basonym, Cytophaga aquatilis Strohl and Tait 1978).
Int. J. Syst. Bacteriol.
46:128-148[Abstract/Free Full Text].
|
| 5.
|
Iida, Y., and A. Mizokami.
1996.
Outbreaks of coldwater disease in wild ayu and pale chub.
Fish Pathol.
31:157-164.
|
| 6.
|
Jo, Y.
1981.
Studies on Vibrio anguillarum infection in cultured ayu and its immunological prophylaxis.
Shikoku Acta Med.
37:82-110.
|
| 7.
|
Kitao, T.
1993.
Streptococcal infections, p. 196-210.
In
V. Inglis, R. J. Roberts, and N. R. Bromage (ed.), Bacterial diseases of fish. Blackwell Scientific Publications Ltd., London, United Kingdom.
|
| 8.
|
Kusuda, R.,
K. Kawai,
F. Salati,
C. R. Banner, and J. L. Fryer.
1991.
Enterococcus seriolicida sp. nov., a fish pathogen.
Int. J. Syst. Bacteriol.
41:406-409[Abstract/Free Full Text].
|
| 9.
|
Merino, S.,
S. Camprubi, and J. M. Tomas.
1990.
Isolation and characterization of bacteriophage PM2 from Aeromonas hydrophila.
FEMS Microbiol. Lett.
68:239-244[CrossRef].
|
| 10.
|
Merril, C. R.,
B. Biswas,
R. Carlton,
N. C. Jensen,
G. J. Creed,
S. Zullo, and S. Adhya.
1996.
Long-circulating bacteriophage as antibacterial agents.
Proc. Natl. Acad. Sci. USA
93:3188-3192[Abstract/Free Full Text].
|
| 11.
|
Muroga, K.,
M. Iida,
H. Matsumoto, and T. Nakai.
1986.
Detection of Vibrio anguillarum from waters.
Bull. Jpn. Soc. Sci. Fish.
52:641-647.
|
| 12.
|
Murphy, F. A.,
C. M. Fauquet,
D. H. L. Bishop,
S. A. Ghabrial,
A. W. Jarvis,
G. P. Martelli,
M. A. Mayo, and M. D. Summers (ed.).
1995.
Tailed phages, p. 49-63.
In
Virus taxonomy 6th report of ICTV. Springer-Verlag, New York, N.Y.
|
| 13.
|
Nakai, T.,
R. Sugimoto,
K.-H. Park,
S. Matsuoka,
K. Mori,
T. Nishioka, and K. Maruyama.
1999.
Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail.
Dis. Aquat. Org.
37:33-41[Medline].
|
| 14.
|
Nakatsugawa, T., and Y. Iida.
1996.
Pseudomonas sp. isolated from diseased ayu, Plecoglossus altivelis.
Fish Pathol.
31:221-227.
|
| 15.
|
Nishimori, E.,
K. Kita-Tsukamoto, and H. Wakabayashi.
2000.
Pseudomonas plecoglossicida sp. nov., the causative agent of bacterial hemorrhagic ascites of ayu, Plecoglossus altivelis.
Int. J. Syst. Evol. Microbiol.
50:83-89[Abstract].
|
| 16.
|
Park, K.-H.,
H. Kato,
T. Nakai, and K. Muroga.
1998.
Phage typing of Lactococcus garvieae (formerly Enterococcus seriolicida), a pathogen of cultured yellowtail.
Fish. Sci.
64:62-64.
|
| 17.
|
Park, K.-H.,
S. Matsuoka,
T. Nakai, and K. Muroga.
1997.
A virulent bacteriophage of Lactococcus garvieae (formerly Enterococcus seriolicida) isolated from yellowtail, Seriola quinqueradiata.
Dis. Aquat. Org.
29:145-149.
|
| 18.
|
Paterson, W. D.,
R. J. Douglas,
I. Grinyer, and L. A. McDermott.
1969.
Isolation and preliminary characterization of some Aeromonas salmonicida bacteriophages.
J. Fish. Res. Can.
26:629-632.
|
| 19.
|
Radetsky, P.
1996.
The good virus.
Discover
17:50-58.
|
| 20.
|
Rodgers, C. J.,
J. H. Pringle,
D. H. McCarthy, and B. Austin.
1981.
Quantitative and qualitative studies of Aeromonas salmonicida bacteriophage.
J. Gen. Microbiol.
125:335-345.
|
| 21.
|
Shotts, E. B., Jr., and C. E. Starliper.
1999.
Flavobacterial diseases: columnaris disease, cold-water disease and bacterial gill disease, p. 559-576.
In
P. T. K. Woo, and D. W. Bruno (ed.), Fish diseases and disorders, vol. 3. Viral, bacterial and fungal infections. CAB, I Publishing, New York, N.Y.
|
| 22.
|
Slopek, S.,
B. Weber-Dabrowska,
M. Dabrowski, and A. Kucharewicz-Krukowska.
1987.
Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.
Arch. Immunol. Ther. Exp.
35:569-583.
|
| 23.
|
Smith, H. W., and M. B. Huggins.
1982.
Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics.
J. Gen. Microbiol.
128:307-318[Abstract/Free Full Text].
|
| 24.
|
Smith, H. W., and M. B. Huggins.
1983.
Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs.
J. Gen. Microbiol.
129:2659-2675[Abstract/Free Full Text].
|
| 25.
|
Smith, H. W.,
M. B. Huggins, and K. M. Shaw.
1987.
The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages.
J. Gen. Microbiol.
133:1111-1126[Abstract/Free Full Text].
|
| 26.
|
Smith, H. W.,
M. B. Huggins, and K. M. Shaw.
1987.
Factors influencing the survival and multiplication of bacteriophages in calves and in their environment.
J. Gen. Microbiol.
133:1127-1135[Abstract/Free Full Text].
|
| 27.
|
Soothill, J. S.
1992.
Treatment of experimental infections of mice with bacteriophages.
J. Med. Microbiol.
37:258-261[Abstract/Free Full Text].
|
| 28.
|
Soothill, J. S.
1994.
Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa.
Burns
20:209-211[CrossRef][Medline].
|
| 29.
|
Spencer, R.
1960.
Indigenous marine bacteriophages.
J. Bacteriol.
79:614[Free Full Text].
|
| 30.
|
Stevenson, R. M. W., and D. W. Airdrie.
1984.
Isolation of Yersinia ruckeri bacteriophages.
Appl. Environ. Microbiol.
47:1201-1205[Abstract/Free Full Text].
|
| 31.
|
Wakabayashi, H.,
K. Sawada,
K. Ninomiya, and E. Nishimori.
1996.
Bacterial hemorrhagic ascites of ayu caused by Pseudomonas sp.
Fish Pathol.
31:239-240.
|
| 32.
|
Wakabayashi, H.,
T. Toyama, and T. Iida.
1994.
A study on serotyping of Cytophaga psychrophila isolated from fishes in Japan.
Fish Pathol.
29:101-104.
|
| 33.
|
Wu, J.-L.,
H.-M. Lin,
L. Jan,
Y.-L. Hsu, and L.-H. Chang.
1981.
Biological control of fish bacterial pathogen, Aeromonas hydrophila, by bacteriophage AH1.
Fish Pathol.
15:271-276.
|
Applied and Environmental Microbiology, April 2000, p. 1416-1422, Vol. 66, No. 4
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Stenholm, A. R., Dalsgaard, I., Middelboe, M.
(2008). Isolation and Characterization of Bacteriophages Infecting the Fish Pathogen Flavobacterium psychrophilum. Appl. Environ. Microbiol.
74: 4070-4078
[Abstract]
[Full Text]
-
Huff, W. E., Huff, G. R., Rath, N. C., Donoghue, A. M.
(2006). Evaluation of the Influence of Bacteriophage Titer on the Treatment of Colibacillosis in Broiler Chickens. Poult. Sci.
85: 1373-1377
[Abstract]
[Full Text]
-
Loc Carrillo, C., Atterbury, R. J., El-Shibiny, A., Connerton, P. L., Dillon, E., Scott, A., Connerton, I. F.
(2005). Bacteriophage Therapy To Reduce Campylobacter jejuni Colonization of Broiler Chickens. Appl. Environ. Microbiol.
71: 6554-6563
[Abstract]
[Full Text]
-
Westwater, C., Kasman, L. M., Schofield, D. A., Werner, P. A., Dolan, J. W., Schmidt, M. G., Norris, J. S.
(2003). Use of Genetically Engineered Phage To Deliver Antimicrobial Agents to Bacteria: an Alternative Therapy for Treatment of Bacterial Infections. Antimicrob. Agents Chemother.
47: 1301-1307
[Abstract]
[Full Text]
-
Wolf, A., Wiese, J., Jost, G., Witzel, K.-P.
(2003). Wide Geographic Distribution of Bacteriophages That Lyse the Same Indigenous Freshwater Isolate (Sphingomonas sp. Strain B18). Appl. Environ. Microbiol.
69: 2395-2398
[Abstract]
[Full Text]
-
Mizoguchi, K., Morita, M., Fischer, C. R., Yoichi, M., Tanji, Y., Unno, H.
(2003). Coevolution of Bacteriophage PP01 and Escherichia coli O157:H7 in Continuous Culture. Appl. Environ. Microbiol.
69: 170-176
[Abstract]
[Full Text]
-
Cerveny, K. E., DePaola, A., Duckworth, D. H., Gulig, P. A.
(2002). Phage Therapy of Local and Systemic Disease Caused by Vibrio vulnificus in Iron-Dextran-Treated Mice. Infect. Immun.
70: 6251-6262
[Abstract]
[Full Text]